STUDY OF THE INTERACTION OF THE TRANSLUTAMINASINASE 2 WITH THE TRANSCRIPTION FACTOR P73 IN THE CONTEXT OF TUMOR FORMATION
- Authors: Gnennaya Y.A1, Piacentini M.2, Barlev N.A1
-
Affiliations:
- Institute of Cytology RAS
- University of Rome “Tor Vergata"
- Issue: Vol 15, No 3S (2020)
- Pages: 86-86
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122794
- DOI: https://doi.org/10.23868/gc122794
- ID: 122794
Cite item
Abstract
Full Text
About the authors
Y. A Gnennaya
Institute of Cytology RAS
Email: gnennaya1996@mail.ru
Saint-Petersburg, Russia
M. Piacentini
University of Rome “Tor Vergata"Rome, Italy
N. A Barlev
Institute of Cytology RASSaint-Petersburg, Russia
References
- Nezir A. E., Ulukan, B., Telci, D. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences. 2019; 7(2): 24;
- Tucholski, J. TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation. Amino Acids. 2010; 39(2): 523-532.